Scrip Podcasts
de Norstella
Strategic Intent: Praxis CEO On Unlearning, AI And Launching Two…
Sobre este podcast
Scrip delivers expert-driven audio insight on biopharma — from R&D, commercial strategy and deal activity to coverage of major industry events. Every Monday, Ian Haydock presents Quick Listen: Five Must-Know Things, a weekly roundup of top industry stories. Joseph Haas hosts a quarterly deep-dive into dealmaking with guests from leading companies, law firms and investment firms. Visit https://insights.citeline.com/scrip to sign up. For any podcast feedback or queries, you can now reach us at [email protected].
Episódios
Os 20 episódios mais recentes de 54
- Strategic Intent: Praxis CEO On Unlearning, AI And Launching Two Neuroscience Drugs At Once · 45 minPraxis Precision Medicines is within weeks of FDA decisions on two potential firsts: relutrigine for SCN2A and SCN8A developmental and epileptic encephalopathies, and…
- Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) · 17 min本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年11月13日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本周内容包括:Rasonque的惊艳上市;行业资深人士分享合作智慧;Lp(a)药物市场前景黯淡;ACR会议上细胞疗法展现希望;以及Teva的创新雄心。 Story links here…
- Scrip's Five Must-Know Things - Rasonque's Stellar Launch, Biotech Partnering Tips and Teva's Innovation Pivot · 17 minJoin us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five…
- Strategic Intent: Lundbeck On Reimbursement, Risk And The Return Of Neuroscience · 20 minIn this episode of Strategic Intent, Maria Alfaiate, Executive Vice President for Corporate Portfolio and Product Strategy at Lundbeck, discusses neuroscience's growing…
- Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) · 16 min本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年11月6日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本周内容包括:马德里加尔公司(Madrigal)的MASH项目举报人;礼来(Lilly)将继续推进并购;赛诺菲(Sanofi)正在寻求后期研发资产;辉瑞(Pfizer)上调业绩预期;以及LIB公司PCS…
- Scrip's Five Must-Know Things: Madrigal Whistleblower Case, Lilly & Sanofi Hunting Deals · 16 minJoin us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five…
- Proof of Concept: The Money Is Back In RNA, But What Stands Between Headlines And Routine Medicine? · 40 min"The money is back in RNA. In recent weeks, Merck KGaA agreed to pay about $1.1 billion for Silence Therapeutics, Novartis signed a deal worth up to $7.8 billion with Abogen…
- Rethinking Risk: Why Early Evidence Strategy Matters for Emerging Biotechs · 23 minFor emerging biotech companies, development success is often measured by clinical milestones, safety, and efficacy. However, demonstrating an asset’s value extends beyond…
- Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) · 16 min本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年10月30日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本周内容包括:美国《COINS法案》的影响;葛兰素史克(GSK)在肿瘤领域的业务转型;礼来(Lilly)在KRAS领域的推进;ris-rez为骨肉瘤治疗带来新希望;以及Genmab最新III期临床试验…
- Scrip's Five Must-Know Things: US COINS Impact, GSK's Oncology Turnaround, Lilly's KRAS Push · 16 minJoin us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five…
- Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.26, 2026 · 17 min本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年10月23日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本周内容包括:欧洲肿瘤内科学会(ESMO)会议的关键预期;新一代抗体药物偶联物;冉冉升起的中盘股新星;葛兰素史克(GSK)新型乙肝药物的上市;以及私营企业的重大融资动态。 Story links…
- Scrip's Five Must-Know Things: Key ESMO Readouts, Next-Gen ADCs And Mid-Cap Winners · 16 minJoin us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five…
- Scrip Awards Podcast – Parabilis CEO Mathai Mammen Interview · 29 minAhead of the awards presentation on Dec 2, the Scrip Awards podcast speaks to Mathai Mammen, CEO of Parabilis, one of the shortlisted companies for Biotech of The Year.
- Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.19, 2026 · 17 min本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年10月16日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本周内容包括:Tremfya从Stelara的余烬中崛起;辉瑞将成熟品牌作为试验田;中国科研力量在第三季度交易中大放异彩;Argenx在自身免疫领域取得进展与遭遇挫折;日本力图重振生物制药竞争力。…
- Scrip's Five Must-Know Things - Oct. 19, 2026 · 17 minJoin us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five…
- Scrip's Five Must-Know Things - Oct. 13, 2026 · 16 minJoin us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five…
- Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.14, 2026 · 18 min本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年10月9日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本周内容包括:中国带来的竞争威胁;第三季度并购活动降温;新型肺炎球菌疫苗竞争者;西班牙生物技术公司的战略;以及盐野义制药20亿美元的收购案。 Story links…
- Rethinking Success in Neuroscience Clinical Development · 13 minDespite significant scientific progress in neuroscience, clinical trial success rates remain low. Complex diseases, evolving therapeutic approaches and challenges around endpoint…
- Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.5, 2026 · 17 min本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年10月2日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 谁在引领今年的并购步伐;罗氏(Roche)的研发管线重整;湿性黄斑变性(wet AMD)市场的洗牌;默克公司(Merck &…
- Scrip's Five Must-Know Things - Oct. 5, 2026 · 16 minAudio roundup of selected biopharma industry content from Scrip over the business week ended Oct. 2, 2026. This episode was produced with the help of AI text-to-voice and voice…








